Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
09/2005
09/01/2005CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
08/2005
08/31/2005EP1567501A1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors
08/31/2005EP1567477A1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
08/31/2005EP1567010A1 Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
08/31/2005CN1662571A Compositions for producing aminoplast products and method for producing products from these compositions
08/31/2005CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
08/31/2005CN1662487A Amide linker peroxisome proliferator activated receptor modulators
08/31/2005CN1662230A Benzoic acid derivatives as modulators of PPAR alpha and gamma
08/31/2005CN1660813A Method for distilling liensinine from extracting solution of lotus seed core through separation coupling technique of adsorption-membrane
08/30/2005US6936714 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
08/30/2005US6936325 Optical recording medium
08/25/2005WO2005078060A1 Alkoxylated polyol containing bleach activating terminating functional groups
08/25/2005WO2005077905A1 Fused-ring 4-oxopyrimidine derivative
08/25/2005WO2005077903A2 Melanin concentrating hormone receptor ligands: substituted tetrahydroisoquinoline analogues
08/25/2005WO2005077898A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/25/2005US20050187252 Novel compounds as opioid receptor modulators
08/25/2005CA2554379A1 Alkoxylated polyol containing bleach activating terminating functional groups
08/25/2005CA2552565A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/24/2005EP1566380A1 Isoquinoline compounds and medicinal use thereof
08/24/2005EP1370558B1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
08/24/2005CN1659640A Optical data carrier comprising a cationic aminoheterocyclic dye as light-absorbent compound in the information layer
08/24/2005CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
08/23/2005US6933311 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
08/23/2005US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease
08/18/2005WO2005075432A1 1-(2h)-isoquinolone derivatives and use thereof as anticancer agents
08/18/2005WO2005075431A1 1-(2h)-isoquinolone derivative
08/18/2005WO2005030794A3 Hemiasterlin derivatives and uses thereof
08/18/2005US20050182253 N,N,N',N'-tetrakis(2-quinolylmethyl)ethylenediamine; reacting with Zinc ions; inhibition of photoinduced electron transfer (PET)
08/18/2005US20050182091 For therapy of asthma or chronic obstructive pulmonary disease (COPD) in a mammal
08/18/2005US20050182047 Treatment of demyelinating disorders
08/18/2005US20050182045 Fused ring 4-oxopyrimidine derivative
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1562595A1 Diaryl ethers as opioid receptor antagonists
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/17/2005EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
08/17/2005CN1656076A Iminium positive ion salts in cleaning compositions
08/17/2005CN1215059C Novel heterocyclic compounds and salts thereof and medicinal use of same
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde
08/11/2005US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation
08/11/2005US20050176712 Integrin expression inhibitor
08/11/2005US20050175860 Phenyl pyridine-iridium metal complex compounds for organic electroluminescent device and organic electroluminescent device using thereof
08/10/2005EP1368340B1 Piperazine derivatives as melanocortin receptor agonists
08/09/2005CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
08/09/2005CA2105518C Condensed heterocyclic compounds, their production and use
08/04/2005WO2005070893A2 Azadecalin glucocorticoid receptor modulators
08/04/2005WO2005070891A2 Compounds and methods of use
08/04/2005WO2005070887A1 Bronchorelaxing compounds
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
08/04/2005US20050171181 Histamine-3 receptor modulators
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171109 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
08/04/2005US20050170987 using a polymeric structure of a sugar based polyols and other polyols as starting materials for attachment of organic bleach catalysts; benefits in detergents such as soil suspension, bleaching action and increased surfactant availability in the presence of free hardness
08/04/2005CA2552419A1 Azadecalin glucocorticoid receptor modulators
08/03/2005CN1649844A Isoquinoline derivatives
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1648200A Phenyl pyridine-iridium metal complex compounds for organic electroluminescent device, and organic electroluminescent device using the compounds
08/03/2005CN1213046C Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/02/2005US6924294 A 6-(2-(1(2)H-tetrazol-5-yl)-phenylamino)-1,2,3,4,4a,5,6,7,8,8a -decahydroisoquinoline 3-carboxylic acid derivatives; for treating neurological disorders and neurodegenerative diseases, pain and migraine
08/02/2005US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc.
08/02/2005CA2254972C Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
08/02/2005CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
07/2005
07/28/2005WO2005067502A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
07/28/2005US20050165050 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
07/28/2005US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/28/2005US20050165004 Bronchorelaxing compounds
07/28/2005DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
07/28/2005CA2551869A1 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
07/27/2005EP1556357A1 Compounds, compositions, and methods
07/27/2005EP0986561B1 Compounds for inhibition of ceramide-mediated signal transduction
07/21/2005WO2005066129A2 Bis-pyridino containing compounds for use in the treatment of cns pathologies
07/21/2005WO2005043124A3 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors
07/21/2005US20050159416 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea
07/20/2005EP1555269A1 Phenyl pyridine-iridium metal complex compounds for organic electroluminescent device, process for preparing the compounds, and organic electroluminescent device using the compounds
07/20/2005EP1554243A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases
07/20/2005EP1554239A2 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
07/20/2005CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642917A Non-peptide GnRH antagonists
07/20/2005CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642551A Inhibitors of histone deacetylase
07/20/2005CN1211365C Novel salt of perindopril and pharmacetuical composition contg. same
07/20/2005CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors
07/19/2005US6919470 Aryl and heteroaryl sulfonates
07/19/2005US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
07/19/2005US6919339 ABCA-1 elevating compounds
07/14/2005WO2005064006A1 OPTICALLY ACTIVE, HETEROAROMATIC β-HYDROXY ESTERS, PROCESSES FOR THEIR PREPARATION FROM β-KETO ESTERS AND PROCESSES FOR THE PREPARATION OF THESE β-KETO ESTERS
07/14/2005WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
07/14/2005WO2005063222A1 Hsp90 FAMILY PROTEIN INHIBITOR
07/14/2005WO2005035514A3 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
07/14/2005WO2004113277A8 Methods and compositions for treating amyloid-related diseases
07/14/2005US20050154230 Urea derivatives
07/14/2005US20050154202 Substituted aryl amides
07/14/2005US20050154004 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one's and analogues, optionally mixed with acceptable carriers, excipients or diluents, used for treating multidrug resistant tumors, for inducing apoptosis and as immunology modulators
07/14/2005US20050153941 Cell differntiation inhibiting agent, cell culture method using the same, culture medium, and cultured cell line
07/14/2005US20050153165 Photoactive layer containing a lanthanide complex containing lanthanum(beta-enolate)2(bisphosphine oxide-sulfide)1 or lanthanum(beta-enolate)3(bisphosphine oxide-sulfide)2
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 119